Dr. Jeremy Kratz is an Assistant Professor within the Department of Medicine.
His research interest incudes improving the lives of cancer patients through effective therapeutic strategies especially for primary liver and pancreatic cancer. Patient-derived organotypic models provide an individual culture to improve disease modeling for mechanistic and therapeutic studies.
The Kratz Lab is focused on the translation of patient-derived organoid models of primary liver and pancreatic cancers to overcome mechanisms of molecular heterogeneity in conferring clinically significant resistance. Using a combination of mechanistic studies in organoids and animal models, we aim to develop novel therapeutic strategies that predict mechanisms of resistance at the level of transcriptional regulation.